.png)
.png)
Latest news from BIA
BIA warns there is little time to avoid disruption as government announces ‘no-deal’ Brexit planning
Steve Bates OBE, CEO of the BIA responds to the Written Ministerial Statement on EU Exit preparedness published by the Government today.
UK Biotech forges links with new global investors
The UK BioIndustry Association (BIA) is hosting the key movers from the Hong Kong stock exchange in London this week as part of a strategic push to enable global investors to get to know the opportunities in UK biotech.
World leading antibody scientist Dr Jane Osbourn awarded OBE in Queen’s Honours
Dr Jane Osbourn, Vice-President of Research and Development at AstraZeneca and Chair of the UK BioIndustry Association (BIA) has been made an Officer of the Order of the British Empire (OBE) in the Queen’s birthday honours list.
UK Life Sciences Industry welcomes launch of Health Innovation Research Alliance Northern Ireland
Today, 4 June, sees the unveiling of the UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI) at a BIO reception in Philadelphia hosted by the UK Department for International Trade, Invest Northern Ireland, the Welsh Government, BIA, AstraZeneca and the British American Business Council of Greater Philadelphia. It will be followed by a formal launch event on 5 June at the Union League of Philadelphia from 08:30-10:00 EST.
Medherant positions itself for the next stage of its development with the appointment of a new CEO
Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019. Nigel Davis, the current CEO, will remain with the Company as Chief Business Officer.
Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration
Developing world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy.
Oxford Biomedica named as winner of The Oxford Science Park Innovation Award 2019
Leading gene therapy manufacturer recognised as part of Oxfordshire Business Awards Oxford, UK, June 18 2019 - Its work on life-changing treatments for serious diseases has earned Oxford Biomedica, a leading gene and cell therapy group, The Oxford Science Park Innovation Award 2019.
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK, announce strategic collaboration
Psychiatry Consortium to address unmet patient needs
CEO Update | Monday 24 June 2019
It has been an incredibly busy couple of weeks for our sector, there have been developments with the Brexit timeline, as well as positive domestic news, all coming within a short space of time.
Guest blog | Sean Morgan-Jones | UK Biotech PLC is Totally Smashing It...
‘The UK is leading a two speed Europe’ (McKinsey & Company, Biotech in Europe: Scaling Innovation May 20, 2019). One of the key findings and contrary to the received wisdom, is that the UK is totally smashing it on all measures as a Biotech hot spot according to research presented at BioEquity Europe in Barcelona by McKinsey & Company looking at where's hot and where's not. Of the 1,000 European Biotechs established since 2012 the UK is leading by a country mile and represents 35% of all new Biotechs and according to the report and is leading a two speed Europe (with Germany, France and Spain in relative decline).
CEO Update | Monday 17 June
Today, the BIA is pleased to publish a new report, ‘Life sciences: Catalysing investment and growth”. which sets out how our sector is driving investment and growth across the UK and makes the case for increased cost-effective public investment in the sector. The report aims to inform the Government, UKRI and other policy makers as they prepare for the forthcoming Spending Review and develop an R&D roadmap to reach 2.4% R&D target.
Video of the week | How Engineers Move Medicine Around The World
Medicines have complex storage and transportation needs, and getting medicines to remote locations requires lots of planning, clever engineering and infrastructure. Check out this video from SciShow on YouTube to find out more about how medicines are transported around the world.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector, BIA update: January - April 2018
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2018.
Biotech Financing Update: December 2017 to February 2018
The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financing on the public markets are off to a solid start in 2018.
Pipeline Progressing: The UK's Global Bioscience Cluster in 2017
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
BIA Best practice guide for communicating R&D
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
